An examination of multiple explanations for secondary hyperparathyroidism

被引:1
|
作者
Phelps, Kenneth R. [1 ,2 ]
Mason, Darius L. [3 ,4 ]
机构
[1] Stratton Vet Affairs Med Ctr, Albany, NY 12208 USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Methodist LeBonheur Healthcare, Memphis, TN USA
[4] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
关键词
secondary hyperparathyroidism; chronic kidney disease; phosphate; vitamin D; fibroblast growth factor 23; PARATHYROID-HORMONE; VITAMIN-D; KIDNEY; PHOSPHATE; PHOSPHORUS; CALCIUM; PTH; FGF23; 1,25-DIHYDROXYVITAMIN-D; PATHOGENESIS;
D O I
10.5414/CN110043
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Seven theories address the evolution of secondary hyperparathyroidism (SHPT) as chronic kidney disease (CKD) progresses. The tradeoff-in-the-nephron hypothesis states that the plasma parathyroid hormone ([PTH]) concentration rises because an increased phosphate concentration in the cortical distal nephron ([P](CDN)) reduces the ionized calcium concentration in that segment. In the present study, we compared this hypothesis to its predecessors. Materials and methods: We studied 30 patients with estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73m(2) (mean 29.5). To examine historic theories, we performed regressions of [PTH] on plasma concentrations of ionized calcium, phosphorus, 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, and fibroblast growth factor 23, and on calcium excreted per volume of filtrate (E-Ca/C-cr). To assess the tradeoff-in-the-nephron hypothesis, we examined regressions of [PTH] on 100/eGFR and phosphorus excreted per volume of filtrate (E-P/C-cr). Results: Regressions pertinent to historic theories yielded significant direct relationships between [PTH] and both E-Ca/C-cr and [FGF23], but neither association supported the theory to which it pertained. [PTH] varied directly with 100/eGFR and with E-P/C-cr, a surrogate for [P](CDN). E-P/C-cr correlated strongly with 100/eGFR. Conclusions: The only theory of SHPT that our data support is the tradeoff-in-the-nephron hypothesis. Other theories are not supported.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [21] Surgery for Secondary Hyperparathyroidism. Total or Subtotal?
    Birsen, Onur
    Ozban, Murat
    Ozden, Akin
    Sungurtekin, Ugur
    Erdem, Ergun
    Kabay, Burhan
    Yilmaz, Sevda
    Aykota, Muhammed Rasid
    Ozgen, Utku
    Demirci, Samet
    Aydin, Huseyin Cagatay
    INDIAN JOURNAL OF SURGERY, 2022, 84 (01) : 94 - 99
  • [22] Vitamin D analogs for the treatment of secondary hyperparathyroidism
    Slatopolsky, E
    Brown, AJ
    BLOOD PURIFICATION, 2002, 20 (01) : 109 - 112
  • [23] The role of vitamin D in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure
    Vezzoli, Giuseppe
    Arcidiacono, Teresa
    Cozzolino, Mario
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2006, 3 (01) : 60 - 70
  • [24] Intravenous Alfacalcidol Once Weekly Pulse Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients
    El-Shafey, Eid Mohamed
    Alsahow, Ali Eid
    El-Nagar, Gamal Fathy
    Ezzat, Amal
    RENAL FAILURE, 2011, 33 (03) : 329 - 333
  • [25] High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina
    Douthat, Walter G.
    Castellano, Mauro
    Berenguer, Leandro
    Alejandra Guzman, M.
    de Arteaga, Javier
    Chiurchiu, Carlos R.
    Massari, Pablo U.
    Garay, Gabriela
    Capra, Raul
    de la Fuente, Jorge L.
    NEFROLOGIA, 2013, 33 (05): : 657 - 666
  • [26] Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism
    Phelps, Kenneth R.
    NUTRIENTS, 2017, 9 (05):
  • [27] miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease
    Xu, Mingzhi
    Li, Hong
    Bai, Yafei
    He, Jiqing
    Chen, Ruman
    An, Na
    Li, Yongyong
    Dong, Yishan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 361 (05) : 624 - 634
  • [28] Cinacalcet Treatment for Secondary Hyperparathyroidism in Dialysis Patients: An Observational Study in Routine Clinical Practice
    Bover, Jordi
    Perez, Rafael
    Molina, Manuel
    Benavides, Beatriz
    Ariza, Francisco
    Luis Miguel, Jose
    Tornero, Fernando
    Vicens Torregrosa, Josep
    NEPHRON CLINICAL PRACTICE, 2011, 118 (02): : C109 - C121
  • [29] Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
    Koizumi, Masahiro
    Komaba, Hirotaka
    Nakanishi, Shohei
    Fujimori, Akira
    Fukagawa, Masafumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (02) : 784 - 790
  • [30] Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats
    Hasegawa, Tomoka
    Tokunaga, Shin
    Yamamoto, Tomomaya
    Sakai, Mariko
    Hongo, Hiromi
    Kawata, Takehisa
    Amizuka, Norio
    ENDOCRINOLOGY, 2023, 164 (04)